Effects of ossein-hydroxyapatite compound on ewe bone remodeling: biochemical and histomorphometric study

Clin Rheumatol. 1991 Sep;10(3):269-73. doi: 10.1007/BF02208688.

Abstract

Ossein-hydroxyapatite compound (OHC) is a protein-mineral complex derived from bovine bone. Its effects on bone remodeling were studied in old ewes which have seasonal variations in bone remodeling. Seven animals received 200 mg OHC/kg b.w./day for 90 days from July to September. The control group consisted of 7 untreated animals followed for the same period of time. OHC was administered through a fistula into the fourth stomach. A significant decrease of bone histomorphometric parameter values was noted in controls at the end of the experiment, due to seasonal variations: the cancellous eroded perimeter decreased by 45%, the osteoblastic perimeter by 60% and the bone formation rate at the cell level by 20%. In contrast, in the treated-group, these parameters tended to increase or did not change. In conclusion, counteracting the significant seasonal reduction of bone remodeling in ewes, OHC seems able to stimulate directly or indirectly bone metabolism, especially when osteoblast activity is reduced and may partly prevent the seasonal reduction of bone turnover.

MeSH terms

  • Animals
  • Biopsy
  • Bone Remodeling / drug effects*
  • Bone and Bones / drug effects
  • Bone and Bones / pathology
  • Durapatite
  • Female
  • Hydroxyapatites / pharmacology*
  • Sheep

Substances

  • Hydroxyapatites
  • Durapatite